Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

26.42
-0.2000-0.75%
Volume:19.89M
Turnover:526.29M
Market Cap:150.22B
PE:19.43
High:26.71
Open:26.35
Low:26.20
Close:26.62
52wk High:27.94
52wk Low:20.92
Shares:5.69B
Float Shares:5.68B
Volume Ratio:0.90
T/O Rate:0.35%
Dividend:1.72
Dividend Rate:6.51%
EPS(TTM):1.36
EPS(LYR):1.36
ROE:8.89%
ROA:5.68%
PB:1.74
PE(LYR):19.36

Loading ...

European Stocks Close Lower in Tuesday Trading; UK Unemployment Rises to 5.1%

MT Newswires Live
·
Jan 21

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Reuters
·
Jan 21

Pfizer CEO Albert Bourla on Drug Prices: They Are Coming Down - CNBC Interview

THOMSON REUTERS
·
Jan 21

GSK, Shionogi reach agreement with Pfizer for interest in ViiV Healthcare

TIPRANKS
·
Jan 20

Novavax Signs License Agreement With Pfizer for Matrix-M Adjuvant Technology

Reuters
·
Jan 20

Novavax: Pfizer to Have Control of Matters Relating to Development, Manufacture & Commercialization of Products That Contain Adjuvant

THOMSON REUTERS
·
Jan 20

Shionogi Boosts Stake in ViiV Healthcare as Pfizer Exits Joint HIV Venture

TIPRANKS
·
Jan 20

Japan's Shionogi boosts ViiV stake to 21.7% as Pfizer exits

Reuters
·
Jan 20

GSK - Pfizer to Receive $1.875 Bn, GSK Special Dividend of $0.250 Bn

THOMSON REUTERS
·
Jan 20

On the Ground at Davos: Pfizer, Microsoft Among Sponsors of "America House," Rumored Costs Reach $1 Million

Deep News
·
Jan 19

ANALYSIS-American CEOs push back on Trump ... mildly

Reuters
·
Jan 17

Pfizer-backed Agomab Therapeutics reveals wider loss in US IPO filing

Reuters
·
Jan 17

Agomab Therapeutics Nv: 5.73% of Common Shares Beneficially Owned by Pfizer Before Offering

THOMSON REUTERS
·
Jan 17

Mixed options sentiment in Pfizer with shares down 0.64%

TIPRANKS
·
Jan 17

Notable open interest changes for January 16th

TIPRANKS
·
Jan 16

Congresswoman Violates STOCK Act With Over 200 Late Trade Disclosures: Purchases Include Mag7, Healthcare Stocks

Benzinga_recent_news
·
Jan 16

Stocks With Juicy Dividends Are Tempting. But How Risky Are They? -- Barrons.com

Dow Jones
·
Jan 16

Assessing Madrigal Pharmaceuticals (MDGL) Valuation After New Pfizer Partnership In Metabolic Liver Disease

Simply Wall St.
·
Jan 16

Health Rounds: First human coronary bypass surgery performed without chest cracking

Reuters
·
Jan 16

Pfizer Advances Prazosin Manufacturing Shift With New Bioequivalence Study

TIPRANKS
·
Jan 16